BioCentury | Apr 28, 2020
Finance

April 27 Quick Takes: Avalyn raises $35M for fibrosis therapies, plus Actym, LifeSprout, HebeCell, Compass, Immunomic

...in a series A round led by Redmile Group LLC with participation from Nexus Management, Emerald...
BioCentury | Aug 26, 2019
Company News

Management tracks: Grail, Boehringer, Torque, Bellus and Emerald

...She was VP, respiratory therapy area head at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). Cannabinoid-based therapeutics company Emerald...
...previously held their respective roles at Zafgen Inc. (NASDAQ:ZFGN). Mary Romeo, Assistant Editor Bellus Health Inc. Boehringer Ingelheim GmbH Emerald...
BioCentury | Feb 9, 2017
Tools & Techniques

Preclinical autopilot

...of Transcriptic Inc. Transcriptic is one of a batch of emerging cloud-based CROs that include Emerald...
...Cloud Laboratory , Arcturus BioCloud Inc. and in vivo -based Vium Inc. Transcriptic, Vium and Emerald...
...in the reproducibility crisis that has dogged preclinical research, in particular in academia, she said. Emerald...
BioCentury | Jan 27, 2017
Clinical News

Seciera: Ph III Emerald data

...Top-line data from the double-blind, U.S. Phase III Emerald trial in 744 patients with dry eye...
BioCentury | Jul 14, 2014
Financial News

Emerald Therapeutics Inc completes venture financing

Emerald Therapeutics Inc ., Menlo Park, Calif. Business: Supply/Service, Infectious Date completed: 2014-07-01 Type: Venture financing Raised: $6 million Investors: Founders Fund; Schooner Capital; private investor WIR Staff...
BioCentury | Jul 2, 2014
Financial News

Emerald Therapeutics closes $6M series B, launches Emerald Cloud Lab

...of eBay Inc. (NASDAQ:EBAY). New investor Schooner Capital also participated. Emerald Therapeutics also launched its Emerald...
...MALDI) mass spectrometry. Emerald plans to support over 100 standard experiment types within 18 months. Emerald...
...efforts. The company is developing a pipeline of preclinical therapeutics to cure persistent viral infections. Emerald...
BioCentury | Jan 20, 2014
Company News

Emerald Bio, NanoRacks, Protein BioSolutions, Broad Institute, CASIS deal

...Drug discovery company Emerald Bio partnered with the Broad Institute, CASIS and NanoRacks to explore the...
...of proprotein convertase subtilisin/kexin type 9 (PCSK9) and myeloid leukemia cell differentiation protein (MCL1) . Emerald...
...protein production, purification, characterization and crystallography solutions. The parties could not be reached for details. Emerald...
BioCentury | Mar 4, 2013
Regulation

Two-speed system

...the primary endpoint of the PEARL studies, as well as that of the Phase III EMERALD...
...mean hemoglobin change from baseline. The PEARL trials enrolled about 1,000 non-dialyzed patients, while the EMERALD...
BioCentury | Dec 12, 2011
Clinical News

Peginesatide regulatory update

...of care epoetin alfa for efficacy and safety in dialysis patients in the Phase III EMERALD...
BioCentury | Dec 12, 2011
Regulation

Countdown to showdown

...under the new bundled payment system from the Centers for Medicare & Medicaid Services (CMS). EMERALD...
...III trials: EMERALD 1 (AFX01-12), EMERALD 2 (AFX01-14), PEARL 1 (AFX01-11) and PEARL 2 (AFX01-13). EMERALD...
...epoetin at their current dose 1-3 times per week. The target hemoglobin range in the EMERALD...
Items per page:
1 - 10 of 88
BioCentury | Apr 28, 2020
Finance

April 27 Quick Takes: Avalyn raises $35M for fibrosis therapies, plus Actym, LifeSprout, HebeCell, Compass, Immunomic

...in a series A round led by Redmile Group LLC with participation from Nexus Management, Emerald...
BioCentury | Aug 26, 2019
Company News

Management tracks: Grail, Boehringer, Torque, Bellus and Emerald

...She was VP, respiratory therapy area head at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). Cannabinoid-based therapeutics company Emerald...
...previously held their respective roles at Zafgen Inc. (NASDAQ:ZFGN). Mary Romeo, Assistant Editor Bellus Health Inc. Boehringer Ingelheim GmbH Emerald...
BioCentury | Feb 9, 2017
Tools & Techniques

Preclinical autopilot

...of Transcriptic Inc. Transcriptic is one of a batch of emerging cloud-based CROs that include Emerald...
...Cloud Laboratory , Arcturus BioCloud Inc. and in vivo -based Vium Inc. Transcriptic, Vium and Emerald...
...in the reproducibility crisis that has dogged preclinical research, in particular in academia, she said. Emerald...
BioCentury | Jan 27, 2017
Clinical News

Seciera: Ph III Emerald data

...Top-line data from the double-blind, U.S. Phase III Emerald trial in 744 patients with dry eye...
BioCentury | Jul 14, 2014
Financial News

Emerald Therapeutics Inc completes venture financing

Emerald Therapeutics Inc ., Menlo Park, Calif. Business: Supply/Service, Infectious Date completed: 2014-07-01 Type: Venture financing Raised: $6 million Investors: Founders Fund; Schooner Capital; private investor WIR Staff...
BioCentury | Jul 2, 2014
Financial News

Emerald Therapeutics closes $6M series B, launches Emerald Cloud Lab

...of eBay Inc. (NASDAQ:EBAY). New investor Schooner Capital also participated. Emerald Therapeutics also launched its Emerald...
...MALDI) mass spectrometry. Emerald plans to support over 100 standard experiment types within 18 months. Emerald...
...efforts. The company is developing a pipeline of preclinical therapeutics to cure persistent viral infections. Emerald...
BioCentury | Jan 20, 2014
Company News

Emerald Bio, NanoRacks, Protein BioSolutions, Broad Institute, CASIS deal

...Drug discovery company Emerald Bio partnered with the Broad Institute, CASIS and NanoRacks to explore the...
...of proprotein convertase subtilisin/kexin type 9 (PCSK9) and myeloid leukemia cell differentiation protein (MCL1) . Emerald...
...protein production, purification, characterization and crystallography solutions. The parties could not be reached for details. Emerald...
BioCentury | Mar 4, 2013
Regulation

Two-speed system

...the primary endpoint of the PEARL studies, as well as that of the Phase III EMERALD...
...mean hemoglobin change from baseline. The PEARL trials enrolled about 1,000 non-dialyzed patients, while the EMERALD...
BioCentury | Dec 12, 2011
Clinical News

Peginesatide regulatory update

...of care epoetin alfa for efficacy and safety in dialysis patients in the Phase III EMERALD...
BioCentury | Dec 12, 2011
Regulation

Countdown to showdown

...under the new bundled payment system from the Centers for Medicare & Medicaid Services (CMS). EMERALD...
...III trials: EMERALD 1 (AFX01-12), EMERALD 2 (AFX01-14), PEARL 1 (AFX01-11) and PEARL 2 (AFX01-13). EMERALD...
...epoetin at their current dose 1-3 times per week. The target hemoglobin range in the EMERALD...
Items per page:
1 - 10 of 88